Steris reported $10.71B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
3M USD 39.53B 4.6B Sep/2026
Accuray USD 448.01M 8.81M Dec/2025
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
CONMED USD 2.3B 4.16M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dexcom USD 6.24B 216.5M Sep/2026
Ecolab USD 31.11B 1.18B Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Fortive USD 11.5B 112.2M Sep/2026
Getinge SEK 57.37B 6.55B Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Olympus JPY 1.52T 4.59B Sep/2026
Orthofix International USD 855.76M 17.26M Sep/2026
Owens Minor USD 2.08B 28.5M Sep/2026
ResMed USD 8.21B 754.14M Sep/2026
Steris USD 10.71B 22.5M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026